Factors such as increasing prevalence of chronic diseases, rising aging population, and increasing healthcare expenditure are contributing to the growth of this market.
Indian Peptide and Anticoagulant Drugs Market is projected to reach USD 883.0 Million and USD 170.2 Million by 2022 respectively
MarketsandMarkets™ - Mar 13, 2019